byiShook Opinion
Apr 29, 2025 - 11:15
Regeneron stock tumbled Tuesday after the biotech giant reported a major revenue miss due to light sales of its eye drug Eylea. The post Regeneron Crashes 9% After Eylea Miss Drags Its Earnings Down appeared first on Investor's Business Daily.
Regeneron stock tumbled Tuesday after the biotech giant reported a major revenue miss due to light sales of its eye drug Eylea.
The post Regeneron Crashes 9% After Eylea Miss Drags Its Earnings Down appeared first on Investor's Business Daily.